期刊文献+

小檗碱的降糖作用独立于AMPK的信号通路 被引量:4

Berberine enhances glucose metabolism in absence of AMP-activated protein kinase activation
下载PDF
导出
摘要 目的:研究小檗碱的降糖作用是否依赖于单磷酸腺苷激活蛋白激酶(AMPK)信号途径。方法培养HepG2细胞和C2C12细胞,给予不同浓度小檗碱处理。葡萄糖消耗实验和乳酸生成实验用于检测小檗碱的降糖以及刺激糖酵解的作用。AMPK抑制剂化合物C(Compound C,CC)和显性失活突变型AMPK,即腺病毒负显性AMPK(Ad-DN-AMPK)腺病毒用于抑制AMPK的表达和活性。Western印迹法用于检测AMPK以及乙酰辅酶A羧化酶(ACC)磷酸化水平,以评估AMPK通路的活性。结果小檗碱显著刺激了HepG2细胞和C2C12细胞的葡萄糖消耗和乳酸生成,并表现出剂量依赖性的药物作用。5和10μmol/L的小檗碱显著增加AMPK及其下游蛋白ACC的磷酸化水平。CC和Ad-DN-AMPK腺病毒转染能明显抑制细胞内AMPK信号通路的活性。然而,在AMPK活性被抑制的条件下,小檗碱依然能够显著增加细胞的葡萄糖消耗和乳酸生成。结论小檗碱通过刺激糖酵解而上调细胞的糖代谢,该作用无需AMPK信号通路的参与。即使在AMPK的表达或者活性被抑制的情况下,小檗碱依然能够发挥显著的降糖作用。 Objective To investigate whether berberine exerts hypoglycemic effect in dependence of adenosine 5¢-monophosphate-activated protein kinase (AMPK) signal pathway. Methods After human liver hepatocellular cell line HepG2 and mouse myoblast cell line C2C12 were treated with berberine at different concentrations, glucose consumption and lactate production were used to evaluate the glucose-lowering and anaerobic glycolysis effects of berberine. Compound C (CC), an AMPK inhibitor, and recombinant adenovirus Ad-DN-AMPK expressing dominant negative mutant of AMPK, were used to inhibit the expression and block the activity of AMPK in the cells. AMPK phosphorylation and acetyl coA carboxylase (ACC) phosphorylation were measured with Western blotting to assess the activity of AMPK pathway. Results Berberine significantly increased glucose consumption and lactate production in HepG2 and C2C12 cells in a dose-dependent manner. AMPK and ACC phosphorylation were significantly stimulated by 5 and 10μmol/L berberine. CC and adenovirus-dominant negative-AMPK (Ad-DN-AMPK) adenovirus obviously inhibited AMPK activity, but failed to diminish the promotion of glucose utilization and lactate production induced by berberine. Conclusion Berberine significantly enhances glucose consumption by stimulating glucose metabolism, in absence of AMPK pathway activation. Therefore, even in the case of the expression or activity of AMPK is inhibited, berberine is still able to exert a significant hypoglycemic effect.
出处 《中华老年多器官疾病杂志》 2014年第11期847-851,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 国家自然科学基金(31171128,81200655)和上海浦江人才计划(11PJ1407700)
关键词 小檗碱 糖酵解 乳酸 AMPK berberine adenosine 5¢-monophosphate-activated protein kinase glycolysis lactic acid
  • 相关文献

参考文献15

  • 1殷峻,胡仁明,陈名道,唐金凤,李凤英,陈家伦.小檗碱、齐墩果酸和大蒜新素对糖代谢作用的体外研究[J].北京中医药大学学报,2003,26(2):36-38. 被引量:24
  • 2Yin J, Hu R, Chen M, et al. Effects of berberine on glucose metabolism in vitro [J]. Metabolism, 2002, 51 (11 ): 1439-1443.
  • 3Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis[J]. Am J Physiol Endocrinol Metab, 2008, 294(1): E148-E156.
  • 4Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J]. Metabolism, 2008, 57(5): 712-717.
  • 5殷峻,陈名道,唐金凤,李凤英,周丽斌,杨颖,陈家伦.小檗碱对实验大鼠糖脂代谢的影响[J].中国糖尿病杂志,2004,12(3):215-218. 被引量:54
  • 6殷峻,陈名道,杨颖,唐金凤,李凤英.小檗碱对大鼠脂代谢的影响[J].上海第二医科大学学报,2003,23(B10):28-30. 被引量:23
  • 7Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine[J]. J Lipid Res, 2006, 47(6): 1281-1288.
  • 8Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action[J]. J Clin Invest, 2001, 108(8): 1167-1174.
  • 9Zhang LN, Xu L, Zhou HY, et al. Novel small-molecule AMP-activated protein kinase allosteric activator with beneficial effects in db/db mice[J]. PLoS One, 2013, 8(8): e72092.
  • 10Viollet B, Guigas B, Leclerc J, et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives[J]. Acta Physiol (Oxf), 2009, 196(1): 81-98.

二级参考文献12

  • 1韩娜,王芸,刘斌,王美岭,张卫东,张莉.大蒜素对实验性糖尿病作用机理的研究[J].中国药理学通报,1991,7(6). 被引量:19
  • 2柳占彪,王鼎,王淑珍,哈斯,李浦维.齐墩果酸的降糖作用[J].中国药学杂志,1994,29(12):725-726. 被引量:39
  • 3倪艳霞 刘安张 等.黄连素治疗Ⅱ型糖尿病60例疗效观察及实验研究[J].中西医结合杂志,1988,8(12):711-711.
  • 4江苏新医学院.中药大辞典[M].上海:上海科学技术出版社,1996.551.
  • 5陈其明.黄连及小檗碱降血糖作用的研究[J].药学学报,1986,21(6):401-401.
  • 6Yin J, Hu R, Chen M, et al. Effects of berberine on glucose metabolism in vitro. Metabolism, 2002,51 : 1439-1443.
  • 7McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes [ J ]. Diabetes, 2002, 51(1):7-18.
  • 8Zhou YP, Grill VE. Long - term exposure of rats pancreatic islets to fatty acids inhibits glucose induced insulin secretion and biosynthesis through a glucose fatty acid cycle[ J ]. J Clin Invest, 1994,93 (2) :870 - 876.
  • 9Zhou YP, Ling ZC, Grill VE. Inhibitory effects of fatty acids on glucose - regulated 13 - cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism [ J ]. Metabolism, 1996,45 ( 8 ) :981 - 986.
  • 10高从容,张家庆,黄庆玲.黄连素增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究[J].中国中西医结合杂志,1997,17(3):162-164. 被引量:227

共引文献86

同被引文献36

  • 1殷峻,陈名道,唐金凤,李凤英,周丽斌,杨颖,陈家伦.小檗碱对实验大鼠糖脂代谢的影响[J].中国糖尿病杂志,2004,12(3):215-218. 被引量:54
  • 2何志高,丁奇峰,金丽.二甲双胍与阿卡波糖分别联合胰岛素治疗2型糖尿病的最小成本分析[J].中国药房,2005,16(10):750-751. 被引量:11
  • 3陈名道.脂毒性及其防治的一个关键靶点——AMPK[J].中华内分泌代谢杂志,2007,23(1):5-7. 被引量:13
  • 4陈燕铭.糖尿病的最新诊断标准.国际医药卫生导报,1999,5(5):35-35.
  • 5Whiting DR,Guariguata L,Weil C,et al.IDF diabetes atlas:global estimates of the prevalence of diabetes for2011 and 2030[J].Diabetes Res Clin Pr,2011,94(3):311.
  • 6Fagan TC,Sowers J.Type 2 diabetes mellitus:greater cardiovascular risks and greater benefits of therapy[J].Arch Intern Med,1999,159(10):1 033.
  • 7Yin J,Xing H,Ye J.Efficacy of berberine in palients with type 2 diabetes mellitus[J].Metabolism,2008,57(5):712.
  • 8Choi BH,Ahn IS,Kim YH,et al.Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte[J].Exp Mol Med,2006,38(6):599.
  • 9LunaV, CasaubanL, SajanMP, et al. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3, 4, 5-(PO4)3 in muscle of diabetic subjects[J]. Diabetologia, 2006, 49(2):375–382.
  • 10StolarMW. Insulin resistance, diabetes, and the adipocyte[J]. Am J Health Syst Pharm, 2002, 59(Suppl 9):S3–8.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部